2023
DOI: 10.1088/1741-2552/acad29
|View full text |Cite
|
Sign up to set email alerts
|

Development of an integrated microperfusion-EEG electrode for unbiased multimodal sampling of brain interstitial fluid and concurrent neural activity

Abstract: Objective. To modify off-the-shelf components to build a device for collecting EEG from macroelectrodes surrounded by large fluid access ports sampled by an integrated microperfusion system in order to establish a method for sampling brain interstitial fluid at the site of seizure activity with no bias for molecular size. Approach. Twenty-four 560 µm diameter holes were ablated through the sheath surrounding one platinum-iridium macroelectrode of a standard Spencer depth electrode using a femtosecond UV laser.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Ongoing clinical trials (NCT04692337, NCT04047264) aim to utilize a similar paradigm but with the incorporation of real-time, in situ and subsequent rapid assessment of potential therapeutic biomarkers and metabolomics. Advances in microelectrode and catheter technology including the development of lower profile instruments as well as those that can simultaneously sample brain interstitial fluid and neural activity hold promise for a more integrated, real-time assessment of molecular- and network-level changes in gliomas ( Rajani et al, 2021 ; Stangler et al, 2023 ). Stangler et al demonstrate that an integrated microperfusion-EEG electrode is able to detect epileptiform activity as well as sample interstitial fluid in a pig model with potential future implications of studying glioma-neuronal integration and functional reorganization in situ ( Stangler et al, 2023 ).…”
Section: Integrated Point-of-care Methodologiesmentioning
confidence: 99%
“…Ongoing clinical trials (NCT04692337, NCT04047264) aim to utilize a similar paradigm but with the incorporation of real-time, in situ and subsequent rapid assessment of potential therapeutic biomarkers and metabolomics. Advances in microelectrode and catheter technology including the development of lower profile instruments as well as those that can simultaneously sample brain interstitial fluid and neural activity hold promise for a more integrated, real-time assessment of molecular- and network-level changes in gliomas ( Rajani et al, 2021 ; Stangler et al, 2023 ). Stangler et al demonstrate that an integrated microperfusion-EEG electrode is able to detect epileptiform activity as well as sample interstitial fluid in a pig model with potential future implications of studying glioma-neuronal integration and functional reorganization in situ ( Stangler et al, 2023 ).…”
Section: Integrated Point-of-care Methodologiesmentioning
confidence: 99%